Skip to content

Third regimen for eradication of Helicobacter pylori resistant against first and sdcond regimen

Third regimen for eradication of Helicobacter pylori resistant against first and sdcond regimen - Third regimen for eradication of Helicobacter pylori

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000008375
Enrollment
100
Registered
2012-07-09
Start date
2009-10-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Helicobacter pylori infection

Interventions

Patients receive the regimen shown below. rabeprazole sodium 10 mg X 3 times/day+amoxicillin 500 mg X 3 times/day+ levofloxacin 500 mg once a day for 14 days.

Sponsors

Osaka City University Graduate School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: a person who had first and second regimen for eradication of Helicobacter pylori and failed to eradicate Helicobacter pylori

Exclusion criteria

Exclusion criteria: The subjects who has allergic hypersensitivity against the drugs used in this study. The subjects who are judged to be inappropriate for this study by doctors conducting the study.

Design outcomes

Primary

MeasureTime frame
success for eradication of Helicobacter pylori

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026